Author

Shuzhen Liu

Institution: Huizhou Central People's Hospital

Observed institution: Huizhou Central People's Hospital

ORCID: 0009-0003-7579-0051

Observed ORCID: 0009-0003-7579-0051

OpenAlex ID: A5138258255

Comparative pharmacovigilance of glycaemic adverse-event reporting for alpelisib and capivasertib: A disproportionality analysis of the FDA adverse event monitoring system

2026 · Yongjian Liu, Hao Zhong, et al. · Therapeutic Advances in Drug Safety · 1

Early post-marketing safety profile of resmetirom in FAERS: an exploratory assessment of statin co-reporting

2026 · Yongjian Liu, Jiaru Chen, et al. · Frontiers in Pharmacology

Works count: 2

Citation count: 1

H-index: 1

I10-index: